Hui Jin
Director/Board Member at Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Profile
Hui Jin currently works at Zhejiang Hongyuan Pharmaceutical Co., Ltd., as Director & Manager.
Hui Jin active positions
Companies | Position | Start |
---|---|---|
Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Zhejiang Hongyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Hongyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredient (API) of cardio-cerebral vascular drugs, intermediates, and other chemicals. Its products include intermediates of Atorvastatin Calcium, Rosuvastatin Calcium, Pregabalin, Empagliflozin, Sotagliflozin, Teneligliptin, Betrixaban, Edoxaban, Sacubitril, Baricitinib, Lifitegrast, Roxadustat, Palbociclib, Ribociclib, Abemaciclib, Rucaparib, and Duloxetine. The company was founded on June 16, 2005 and is headquartered in Hangzhou, China. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Zhejiang Hongyuan Pharmaceutical Co., Ltd.
Zhejiang Hongyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Hongyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of active pharmaceutical ingredient (API) of cardio-cerebral vascular drugs, intermediates, and other chemicals. Its products include intermediates of Atorvastatin Calcium, Rosuvastatin Calcium, Pregabalin, Empagliflozin, Sotagliflozin, Teneligliptin, Betrixaban, Edoxaban, Sacubitril, Baricitinib, Lifitegrast, Roxadustat, Palbociclib, Ribociclib, Abemaciclib, Rucaparib, and Duloxetine. The company was founded on June 16, 2005 and is headquartered in Hangzhou, China. | Health Technology |
- Stock Market
- Insiders
- Hui Jin